Close Menu
Home » Twist Bioscience Files Response to Agilent Technologies Lawsuit

Twist Bioscience Files Response to Agilent Technologies Lawsuit

Jan 31, 2017
|
staff reporter

NEW YORK (GenomeWeb) – Nearly a year after Agilent Technologies filed a lawsuit against Twist Bioscience alleging theft of intellectual property, Twist has filed a response denying the allegations and calling Agilent's suit an attempt "to stifle the legitimate and innovative work of a burgeoning start-up company and one of its top executives."

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Scan

Letting Samples Fly

Rady Children's Institute for Genomic Medicine and Deloitte are looking into the use of drones to transport samples for testing. 

Layoffs at 23andMe

Direct-to-consumer genetic testing firm 23andMe is laying off about 100 people.

Dusty Resistance

Researchers from Northwestern University examined dust for antibiotic-resistance genes, New Scientist reports. 

Science Studies Use Single-Cell RNA Sequencing to Study Cell States, Apply Deep Phenotyping to Pregnancy

In Science this week: researchers present a computational method for predicting cellular differentiation state from single-cell RNA sequencing data, and more. 

What's Popular?

In Business News

  1. 23andMe Lays off 100 Employees Across Consumer Business

  2. Adaptive Biotechnologies Prices Public Offering of Stock

  3. Federal Court Whittles Down Fluidigm Lawsuit Against IonPath

  4. New Products Posted to GenomeWeb: Qiagen, IDT, Meridian Bioscience, More

  5. Ontera Developing Single-Pore Sensor for Sepsis, TB, and Zika Diagnostic Testing

    Premium

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.